GB201602802D0 - Method of treatment - Google Patents

Method of treatment

Info

Publication number: GB201602802D0
Authority: GB; United Kingdom
Prior art keywords: treatment
Prior art date: 2016-02-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB1602802.9A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Volution Immuno Pharmaceuticals SA

Original Assignee

Volution Immuno Pharmaceuticals SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2016-02-17

Filing date

2016-02-17

Publication date

2016-03-30

2016-02-17 Application filed by Volution Immuno Pharmaceuticals SA filed Critical Volution Immuno Pharmaceuticals SA

2016-02-17 Priority to GBGB1602802.9A priority Critical patent/GB201602802D0/en

2016-03-30 Publication of GB201602802D0 publication Critical patent/GB201602802D0/en

2017-02-17 Priority to PCT/EP2017/053714 priority patent/WO2017140903A1/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

GBGB1602802.9A 2016-02-17 2016-02-17 Method of treatment Ceased GB201602802D0 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GBGB1602802.9A GB201602802D0 (en)	2016-02-17	2016-02-17	Method of treatment
PCT/EP2017/053714 WO2017140903A1 (en)	2016-02-17	2017-02-17	Method of treatment of complement mediated neurodevelopmental disorder secondary to zika virus infection

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB1602802.9A GB201602802D0 (en)	2016-02-17	2016-02-17	Method of treatment

Publications (1)

Publication Number	Publication Date
GB201602802D0 true GB201602802D0 (en)	2016-03-30

Family

ID=55697811

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB1602802.9A Ceased GB201602802D0 (en)	2016-02-17	2016-02-17	Method of treatment

Country Status (2)

Country	Link
GB (1)	GB201602802D0 (en)
WO (1)	WO2017140903A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL263481B2 (en)	2016-06-14	2024-06-01	Regeneron Pharma	Anti-c5 antibodies and uses thereof
WO2019118556A1 (en)	2017-12-13	2019-06-20	Regeneron Pharmaceuticals, Inc.	Anti-c5 antibody combinations and uses thereof
AU2019468121A1 (en)	2019-09-27	2022-05-12	Volution Immuno Pharmaceuticals Sa	Method of treatment of hematopoietic stem cell transplant associated thrombotic microangiopathy (HSCT-TMA)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1629098B1 (en)	2003-06-02	2009-04-01	Varleigh Limited	Complement inhibitors from ticks
GB0518443D0 (en)	2005-09-09	2005-10-19	Evolutec Ltd	Method of treating myasthenia gravis
GB0617734D0 (en)	2006-09-08	2006-10-18	Evolutec Ltd	Method of treating peripheral nerve disorders
CA2662716C (en)	2006-09-08	2017-11-21	Varleigh Limited	Method of treating respiratory disorders
GB0802116D0 (en)	2008-02-05	2008-03-12	Natural Enviromental Res Counc	Treatment
CA2785612C (en)	2010-01-08	2019-09-10	Varleigh Immuno Pharmaceuticals (Vip) Ltd.	Ev576 for use in the treatment of viral infections of the respiratory tract
GB201410116D0 (en) *	2014-06-06	2014-07-23	Volution Immuno Pharmaceuticals Sa	Method of treatment

2016
- 2016-02-17 GB GBGB1602802.9A patent/GB201602802D0/en not_active Ceased
2017
- 2017-02-17 WO PCT/EP2017/053714 patent/WO2017140903A1/en active Application Filing

Also Published As

Publication number	Publication date
WO2017140903A1 (en)	2017-08-24

Publication	Publication Date	Title
ZA202006746B (en)	2023-03-29	Methods of treatment
GB201701673D0 (en)	2017-03-15	Methods of well treatment
HK1252568A1 (en)	2019-05-31	A method of treatment
HK1248552A1 (en)	2018-10-19	Method of treatment with tradipitant
ZA201903873B (en)	2022-02-23	Methods of treating cochlear synaptopathy
GB201410116D0 (en)	2014-07-23	Method of treatment
EP3684342C0 (en)	2024-04-24	Method of treatment
HK1247818A1 (en)	2018-10-05	Method of treating diseases
GB201706406D0 (en)	2017-06-07	Method of treatment
IL253028A0 (en)	2017-08-31	Method of treatment
GB201815588D0 (en)	2018-11-07	Method of treatment
IL261850B (en)	2022-04-01	Methods of vitamin d treatment
GB201416832D0 (en)	2014-11-05	Methods of treatment
EP3490547A4 (en)	2020-04-01	Method of treatment
GB201602802D0 (en)	2016-03-30	Method of treatment
SG11202005850VA (en)	2020-07-29	Methods of treatment of hypertrigl yceridemia
HK1250243A1 (en)	2018-12-07	A method of treatment
HK1243937A1 (en)	2018-07-27	Methods of treating diseases
GB2558216B (en)	2019-12-04	Method of heat treatment
GB201512139D0 (en)	2015-08-19	Methods of treatment
GB201720439D0 (en)	2018-01-24	Method of treatment
GB201718589D0 (en)	2017-12-27	Method of treatment
GB201709554D0 (en)	2017-08-02	Method of treatment
GB201706642D0 (en)	2017-06-07	Method of treatment
GB201706452D0 (en)	2017-06-07	Method of treatment

Legal Events

Date	Code	Title	Description
2017-08-16	AT	Applications terminated before publication under section 16(1)